These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11216979)

  • 1. Can we assess the efficacy of therapy in neurocardiogenic syncope?
    Sra JS
    J Am Coll Cardiol; 2001 Feb; 37(2):560-1. PubMed ID: 11216979
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
    Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
    J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with neurally mediated syncope following tilt table testing.
    Sheldon RS
    Cardiologia; 1997 Aug; 42(8):795-802. PubMed ID: 9286117
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of nonselective versus beta-1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope.
    Dendi R; Goldstein DS
    Am J Cardiol; 2002 Jun; 89(11):1319-21. PubMed ID: 12031740
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing.
    Ammirati F; Colivicchi F; Santini M
    Am J Cardiol; 2000 Aug; 86(4):472-4. PubMed ID: 10946050
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers in syncope: the jury is still out.
    Sheldon RS; Raj SR; Rose S; Connolly SJ
    J Am Coll Cardiol; 2001 Dec; 38(7):2135-6. PubMed ID: 11738330
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of serotonin re-uptake inhibitors in preventing recurrent unexplained childhood syncope -- a preliminary report.
    Lenk M; Alehan D; Ozme S; Celiker A; Ozer S
    Eur J Pediatr; 1997 Oct; 156(10):747-50. PubMed ID: 9365060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A
    Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical findings as predictors of positivity of head-up tilt table test in neurocardiogenic syncope.
    Asensio E; Oseguera J; Loría A; Gómez M; Narváez R; Dorantes J; Hernández P; Orea A; Rebollar V; Ocaranza R
    Arch Med Res; 2003; 34(4):287-91. PubMed ID: 12957525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
    Ammirati F; Colivicchi F; Santini M;
    Circulation; 2001 Jul; 104(1):52-7. PubMed ID: 11435337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
    Eldadah BA; Pechnik SL; Holmes CS; Moak JP; Saleem AM; Goldstein DS
    Clin Sci (Lond); 2006 Sep; 111(3):209-16. PubMed ID: 16634720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study.
    Ector H
    Europace; 2010 Jun; 12(6):910. PubMed ID: 20179177
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of pacing in the treatment of vasovagal syncope.
    Sheldon R
    Am J Cardiol; 1999 Oct; 84(8A):26Q-32Q. PubMed ID: 10568558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tilt training: Does it have a role in preventing vasovagal syncope?
    Abe H; Kohno R
    Pacing Clin Electrophysiol; 2008 May; 31(5):641; author reply 641-2. PubMed ID: 18439188
    [No Abstract]   [Full Text] [Related]  

  • 17. Tilt training: does it have a role in preventing vasovagal syncope?
    Gurevitz O; Barsheshet A; Bar-Lev D; Zimlichman E; Rosenfeld GF; Benderly M; Luria D; Amital H; Kreiss Y; Eldar M; Glikson M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1499-505. PubMed ID: 18070305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-suited for prevention of syncope in patients with vasovagal syncope: a pilot study.
    Rasmeehirun P; Krittayaphong R
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S162-7. PubMed ID: 24772594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic approaches to therapy for vasovagal syncope.
    Calkins H
    Am J Cardiol; 1999 Oct; 84(8A):20Q-25Q. PubMed ID: 10568557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the recently modified pacemaker guidelines for neurocardiogenic syncope also apply to young patients? Analysis based on five-year follow-up of israeli soldiers with syncope and a positive tilt test.
    Wagshal AB; Weinstein JM; Weinstein O; Zeldetz V; Damri E; Ilia R; Katz A
    Cardiology; 2004; 102(4):200-5. PubMed ID: 15452388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.